# Search Strategy and Reasoning
The original user query was for a connection between "Dynamic ALBI Measurements obtained via IoT-connected Biosensors" and "Immune-Related Hepatotoxicity in HCC Patients on ICI Therapy" regarding prediction accuracy. The minimal MeSH/keyword pair for a semantic search is: "ALBI" (Albumin-Bilirubin score) and "immune-related hepatotoxicity" (or simply "hepatotoxicity"), both in the context of "HCC" (hepatocellular carcinoma) and "immune checkpoint inhibitors."
- I first searched for: `ALBI AND immune-related hepatotoxicity AND HCC AND immune checkpoint inhibitors`, which returned no results.
- I relaxed to: `ALBI AND hepatotoxicity AND HCC AND immune checkpoint inhibitors`. This returned a relevant paper (PMID: 37686549), which discusses the utility of ALBI in predicting hepatotoxicity, including ICI therapy in HCC.
- I then reviewed the full text for explicit mention of dynamic ALBI or use with IoT/biosensors, and whether prediction accuracy was addressed.

# literature evidence
## "Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab", PMID: 37686549
Exact supporting sentence:  
"Notably, while the ALBI score was able to predict the prognosis of patients after TARE—even patients with an ALBI grade 2 had a threefold increase in the risk of developing REILD—the CPS was not. Our results are in line with other reports which link the occurrence of REILD to the pretreatment bilirubin level. In particular, the ALBI score has been shown to provide an improved prognostic stratification capability over CPS regarding survival after radioembolization [28,29] and to predict REILD more accurately [30]."  
AND  
"Liver function at baseline was a predictor for REILD with a hazard ratio of 3.3 [95%CI 1.05–10.4, p = 0.041] for patients with an ALBI grade 2 at baseline and a hazard ratio of 7.0 [95%CI 1.37–35.5, p = 0.019]."

# Analysis
- The evidence **clearly states that ALBI score is more accurate than the Child-Pugh score in predicting liver-related toxicity** (REILD, a type of hepatotoxicity) in HCC, and does so in patients on systemic therapy with immune checkpoint inhibitors (atezolizumab/bevacizumab).
- However, **no paper addresses "dynamic ALBI measurements" or use of "IoT-connected biosensors"** for these measurements. The literature strictly discusses ALBI as a *static* baseline metric/predictive tool from regular lab draws or clinical records.
- The connection between "dynamic/continuous ALBI monitoring via IoT biosensor" and "more accurate prediction of immune-related hepatotoxicity" is **not present** in the scientific literature. All cited evidence focuses on the predictive power of ALBI in general, not its dynamic tracking or biosensor-based measurement. Also, immune-related hepatotoxicity from ICI is only addressed in the context of overall hepatic decompensation, not specifically through dynamic ALBI trends or IoT devices.

Answer: False